Cargando…
Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologist
Essential thrombocytosis (ET) is a rare haematological malignancy, with an incidence rate of 1.5–2.5/100,000 per year. For many patients with ET the first manifestation of their underlying disease is a thrombotic or haemorrhagic complication. A recent retrospective study revealed an incidence rate o...
Autores principales: | Kuipers, R. S., Kok, L., Virmani, R., Tefferi, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516821/ https://www.ncbi.nlm.nih.gov/pubmed/36757576 http://dx.doi.org/10.1007/s12471-023-01757-4 |
Ejemplares similares
-
Designing a Scoring System for Differential Diagnosis From Reactive Thrombocytosis and Essential Thrombocytosis
por: Shen, Chih-Lung, et al.
Publicado: (2021) -
Essential Thrombocytosis in Patients <40 Years Old With Acute Coronary Syndromes: A Not So Uncommon Underlying Diagnosis Often Overlooked
por: Kok, Lisa, et al.
Publicado: (2022) -
Outcomes of patients with essential thrombocythemia and unnoticed thrombocytosis prior to diagnosis
por: Lee, Myung-Won, et al.
Publicado: (2020) -
Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
por: van Cleemput, Johan, et al.
Publicado: (2018) -
AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management
por: Witteles, Ronald M., et al.
Publicado: (2019)